Hillary Lin, MD

734 posts

Hillary Lin, MD banner
Hillary Lin, MD

Hillary Lin, MD

@HillaryLinMD

Stanford MD & longevity entrepreneur. CEO @goCareCore— helping experts launch science-backed storefronts | Host, The Longevity Show

Manhattan, NY Katılım Temmuz 2009
789 Takip Edilen1.2K Takipçiler
Sabitlenmiş Tweet
Hillary Lin, MD
Hillary Lin, MD@HillaryLinMD·
The most promising longevity drug isn't a peptide or metformin. It's the Shingles vaccine. New data shows it slows biological aging and lowers systemic inflammation for 4+ years post-shot. We are seeing a 20% reduction in new dementia diagnoses and a 25% lower risk of stroke. Stop waiting for a magic pill. One is already on the shelf.
Hillary Lin, MD tweet mediaHillary Lin, MD tweet mediaHillary Lin, MD tweet mediaHillary Lin, MD tweet media
New York, USA 🇺🇸 English
222
918
4.1K
304.4K
Hillary Lin, MD
Hillary Lin, MD@HillaryLinMD·
@SatchinPanda It's interesting, altho just points at whole blood - cellular levels are more significant. That being said, this is just one sign among many, and the solution isn't simply to supplement to "reverse age"
English
0
0
0
38
Satchin Panda
Satchin Panda@SatchinPanda·
Blood NAD+ may not be the aging biomarker many hoped for. Across 7 human cohorts, whole-blood NAD+ levels stayed remarkably stable with age and lifestyle changes—shifting mainly with nicotinamide riboside supplementation. #Aging #NAD #Longevity nature.com/articles/s4225…
Satchin Panda tweet media
English
4
8
44
2.9K
Hillary Lin, MD
Hillary Lin, MD@HillaryLinMD·
@operationdanish Congrats - the interesting part to me is whether AI lowers the coordination cost of longitudinal care, not just the visit itself. That’s where hybrid models either compound or relieve operational drag.
English
1
0
1
50
Dr Danish
Dr Danish@operationdanish·
Some of you have been wondering what I've been up to recently. Well, yesterday, I had the chance to sit down with Matthew Miller at Bloomberg to talk about our work at Rezilient Health - the model, our 400% annual growth rate and what’s next for AI in healthcare.
English
15
8
52
5.9K
Hillary Lin, MD
Hillary Lin, MD@HillaryLinMD·
This is the impt distinction: NAD biology is real, but “low NAD because aging → buy this infusion/supplement” is doing too much work. Blood NAD also seems especially vulnerable to assay/handling issues. Also even if decline is somehow real, answer isn't necessarily to supplement, but rather tackle the mechanism @BuckInstitute
English
0
0
0
245
Hillary Lin, MD
Hillary Lin, MD@HillaryLinMD·
8/ Questions for your next lipid visit: • What’s my ApoB? • Have I checked Lp(a)? • What target fits my risk? • Should we add ezetimibe? • Am I a PCSK9/inclisiran candidate? • Would imaging change the plan? Full episode: youtu.be/qkSrZdt9DUs?t=…
YouTube video
YouTube
Hillary Lin, MD tweet media
New York, USA 🇺🇸 English
0
0
0
19
Hillary Lin, MD
Hillary Lin, MD@HillaryLinMD·
7/ Lifestyle matters. Biology still counts. If your lipids stay high despite doing the “right” things, that doesn’t mean you failed at health. Sometimes medication is just the right tool for a biological risk pattern.
Hillary Lin, MD tweet media
New York, USA 🇺🇸 English
1
0
0
16
Hillary Lin, MD
Hillary Lin, MD@HillaryLinMD·
Your LDL isn’t the whole cholesterol story. LDL is the cargo. ApoB counts the trucks. If the trucks are high, risk can be high even when the cargo number looks “fine.” The modern lipid visit should be about lifetime plaque/event risk — not one lab value. 🧵 1/8
Hillary Lin, MD tweet mediaHillary Lin, MD tweet media
New York, USA 🇺🇸 English
1
0
2
125

Keşfet

@SatchinPanda @operationdanish @BuckInstitute @NPR @EricTopol @JoannaStern @elonmusk @BarackObama